Clinical experience with oral ketamine

Journal of Pain and Symptom Management

Volumn 17, Issue 5, 1999, Pages 384-386

  Enarson, Mark C ^a   Hays, Helen ^a   Woodroffe, Mary Ann ^a   Bscn, ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Analgesia; Neuropathic pain; NMDA; Oral ketamine

Indexed keywords

ANALGESIC AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SLEEP DISORDER;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CHRONIC DISEASE; FEMALE; HUMANS; KETAMINE; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PAIN; RETROSPECTIVE STUDIES;

EID: 0032942235     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00011-1     Document Type: Article

References (17)

1. Lodge D., Johnson K.M. Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci. 11:1990;81-86.
2. US Pharmacopoeia Dispensing Information Ketamine - systemic. 1993;Rand McNally, Rockville.
3. Backonja M., Arndt G., Gombar K.A., Check B., Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine. a preliminary study Pain. 56:1994;51-57.
4. Mathisen L.C., Skjelbred P., Skoglund L.A., Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain. 61:1995;215-220.
5. Eide P.K., Jorum E., Stubhaug A., Bremnes J., Brevik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine. a double-blind, cross-over comparison with morphine and placebo Pain. 58:1994;347-354.
6. Eide P.K., Stubhaug A., Oye I., Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 61:1995;221-228.
7. Felsby S., Nielsen J., Arendt-Nielsen L., Jensen T.S. NMDA receptor blockade in chronic neuropathic pain. a comparison of ketamine and magnesium chloride Pain. 64:1995;283-291.
8. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., Jensen T.S. The effect of ketamine on phantom pain. a central neuropathic disorder maintained by peripheral input Pain. 67:1996;69-77.
9. Rabben T, Oye I. Long-term inhibition of neuropathic orofacial pain by ketamine, an NMDA receptor inhibitor (Abst). In: Eighth World Congress on Pain. Seattle: IASP Press, 1996:154.
10. White T., Way W.L., Trevor A.J. Ketamine - its pharmacology and therapeutic uses. Anesthesiology. 56:1982;119-136.
11. Stannard C.F., Porter G.E. Ketamine hydrochloride in the treatment of phantom limb pain. Pain. 54:1993;227-230.
12. Jensen M.P., Karoly P. Motivation and expectancy factors in symptom perception. a laboratory study of the placebo effect Psychosom Med. 53:1991;144-152.
13. Reich D.L., Silvay G. Ketamine. an update on the first twenty-five years of clinical experience Can J Anaesth. 36:1989;186-197.
14. Meller S.T. Ketamine. relief from chronic pain through actions at the NMDA receptor? (Letter) Pain. 68:1996;435-436.
15. Craig K.D. Emotional aspects of pain. Wall P.D., Melzack R.A. Textbook of pain. 2nd ed:1989;220-230 Churchill Livingstone, Edinburgh.
16. Hagen N., Flynne P., Hays H., MacDonald N. Guidelines for managing chronic non-malignant pain. Can Fam Physician. 41:1995;49-53.
17. Hansson P. Neurogenic pain. diagnosis and treatment IASP Pain Clinical Updates. Seattle: IASP Press. 2:1994;1-4.